Jiangsu Alphamab, 3D Medicines and Glenmark sign license agreement for Envafolimab
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America